Stryker Other Operating Income or Expenses 2010-2025 | SYK

Stryker annual/quarterly other operating income or expenses history and growth rate from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Stryker other operating income or expenses for the quarter ending March 31, 2025 were $-35M, a 1066.67% increase year-over-year.
  • Stryker other operating income or expenses for the twelve months ending March 31, 2025 were $-1.009B, a 33533.33% increase year-over-year.
  • Stryker annual other operating income or expenses for 2024 were $-0.977B, a 2613.89% increase from 2023.
  • Stryker annual other operating income or expenses for 2023 were $-0.036B, a 86.67% decline from 2022.
  • Stryker annual other operating income or expenses for 2022 were $-0.27B, a 162.14% increase from 2021.
Stryker Annual Other Operating Income or Expenses
(Millions of US $)
2024 $-977
2023 $-36
2022 $-270
2021 $-103
2020 $-17
2019 $-192
2018 $-23
2017 $-173
2016 $-158
2015 $-296
2014 $-761
2013 $-760
2012 $-174
2011 $-122
2010 $-182
2009 $0
Stryker Quarterly Other Operating Income or Expenses
(Millions of US $)
2025-03-31 $-35
2024-12-31 $-974
2024-09-30
2024-06-30
2024-03-31 $-3
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $-256
2022-09-30 $4
2022-06-30 $-4
2022-03-31 $-14
2021-12-31 $-5
2021-09-30 $-16
2021-06-30 $-76
2021-03-31 $-6
2020-12-31 $-21
2020-09-30 $-2
2020-06-30
2020-03-31 $6
2019-12-31 $-13
2019-09-30 $-49
2019-06-30 $-117
2019-03-31 $-13
2018-12-31 $-13
2018-09-30 $-4
2018-06-30 $-2
2018-03-31 $-4
2017-12-31 $-9
2017-09-30 $-66
2017-06-30 $-72
2017-03-31 $-26
2016-12-31 $-54
2016-09-30 $-57
2016-06-30 $-28
2016-03-31 $-19
2015-12-31 $118
2015-09-30 $-150
2015-06-30 $-161
2015-03-31 $-103
2014-12-31 $-17
2014-09-30 $-79
2014-06-30 $-276
2014-03-31 $-389
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $-143
2012-09-30
2012-06-30 $-31
2012-03-31
2011-12-31 $-91
2011-09-30 $-31
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $9
2009-09-30 $-9
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $144.946B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $231.485B 27.83
Boston Scientific (BSX) United States $154.809B 38.76
EssilorLuxottica (ESLOY) France $134.105B 0.00
Medtronic (MDT) Ireland $108.260B 15.35
Haleon (HLN) United Kingdom $50.025B 28.46
Lonza Group Ag (LZAGY) Switzerland $49.059B 0.00
ResMed (RMD) United States $36.038B 27.07
GE HealthCare Technologies (GEHC) United States $31.860B 15.13
Agilent Technologies (A) United States $31.051B 20.51
Terumo (TRUMY) Japan $27.450B 35.65
Insulet (PODD) United States $22.837B 89.64
Koninklijke Philips (PHG) Netherlands $22.023B 15.83
Zimmer Biomet Holdings (ZBH) United States $18.348B 11.78
Baxter (BAX) United States $15.616B 11.66
Smith & Nephew SNATS (SNN) United Kingdom $12.578B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.204B 21.59
Lantheus Holdings (LNTH) United States $5.198B 13.11
Prestige Consumer Healthcare (PBH) United States $4.172B 18.64
Perrigo (PRGO) Ireland $3.700B 9.38
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Haemonetics (HAE) United States $3.362B 14.64
ICU Medical (ICUI) United States $3.218B 23.73
Envista Holdings (NVST) United States $2.820B 23.44
GN Store Nord (GNNDY) Denmark $2.097B 17.37
QuidelOrtho (QDEL) United States $2.000B 13.76
LeMaitre Vascular (LMAT) United States $1.841B 41.16
AtriCure (ATRC) United States $1.647B 0.00
Neogen (NEOG) United States $1.350B 17.28
Acuren (TIC) United States $1.305B 0.00
AdaptHealth (AHCO) United States $1.223B 12.41
Kestra Medical Technologies (KMTS) United States $1.186B 0.00
Green Thumb Industries (GTBIF) United States $1.169B 26.29
BioLife Solutions (BLFS) United States $1.049B 0.00
Phibro Animal Health (PAHC) United States $0.942B 12.05
InMode (INMD) Israel $0.898B 9.05
CeriBell (CBLL) United States $0.634B 0.00
Evolus (EOLS) United States $0.618B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.573B 0.00
Curaleaf Holdings (CURLF) Canada $0.554B 0.00
Owens & Minor (OMI) United States $0.531B 4.40
Valneva SE (VALN) France $0.527B 0.00
Capricor Therapeutics (CAPR) United States $0.508B 0.00
Tilray Brands (TLRY) Canada $0.436B 0.00
Surmodics (SRDX) United States $0.416B 0.00
SNDL (SNDL) Canada $0.344B 0.00
Cresco Labs (CRLBF) United States $0.338B 0.00
Canopy Growth (CGC) Canada $0.331B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
VAREX IMAGING (VREX) United States $0.315B 11.58
Aurora Cannabis (ACB) Canada $0.293B 52.20
Sanara MedTech (SMTI) United States $0.276B 0.00
Sanuwave Health (SNWV) United States $0.267B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Verano Holdings (VRNOF) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.237B 10.78
Biote (BTMD) United States $0.212B 5.95
Brainsway (BWAY) Israel $0.196B 52.00
OraSure Technologies (OSUR) United States $0.190B 0.00
Quanterix (QTRX) United States $0.187B 0.00
High Tide (HITI) Canada $0.186B 0.00
Omeros (OMER) United States $0.182B 0.00
Organigram Global (OGI) Canada $0.179B 0.00
TriSalus Life Sciences (TLSI) United States $0.176B 0.00
Utah Medical Products (UTMD) United States $0.173B 14.11
FitLife Brands (FTLF) United States $0.131B 16.07
Jin Medical (ZJYL) China $0.125B 0.00
Exagen (XGN) United States $0.123B 0.00
TerrAscend (TSNDF) Canada $0.113B 0.00
Agape ATP (ATPC) $0.105B 0.00
MacroGenics (MGNX) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.086B 0.00
Fonar (FONR) United States $0.085B 10.96
Quipt Home Medical (QIPT) United States $0.084B 0.00
InterCure (INCR) Israel $0.072B 0.00
Veru (VERU) United States $0.072B 0.00
Zynex (ZYXI) United States $0.069B 0.00
Jushi Holdings (JUSHF) United States $0.066B 0.00
Apyx Medical (APYX) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.055B 0.00
United Health Products (UEEC) United States $0.055B 0.00
Cytosorbents (CTSO) United States $0.054B 0.00
United-Guardian (UG) United States $0.039B 13.44
Modular Medical (MODD) United States $0.035B 0.00
Rockwell Medical (RMTI) United States $0.034B 0.00
Safety Shot (SHOT) United States $0.029B 0.00
Nephros (NEPH) United States $0.024B 32.29
Allurion Technologies (ALUR) United States $0.021B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.011B 0.00
Meihua Medical Technologies (MHUA) China $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.008B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00